Phenylenediamine Urotensin-II receptor antagonists and CCR-9...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C549S029000, C549S059000, C514S438000

Reexamination Certificate

active

10781442

ABSTRACT:
The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

REFERENCES:
patent: 5019587 (1991-05-01), Von der Saal et al.
patent: 5932599 (1999-08-01), Bos et al.
patent: 5962490 (1999-10-01), Chan et al.
patent: 5998439 (1999-12-01), Maynard et al.
patent: 6335334 (2002-01-01), Schindler et al.
patent: 6395759 (2002-05-01), Thompson et al.
patent: 6420567 (2002-07-01), Wu et al.
patent: 6632829 (2003-10-01), Wu et al.
patent: 2003/0064991 (2003-04-01), Harriman et al.
patent: 2005/0049286 (2005-03-01), Wu et al.
patent: 0 344 634 (1989-05-01), None
patent: 0 533 266 (1992-09-01), None
patent: 0 533 267 (1992-09-01), None
patent: 0 533 268 (1992-09-01), None
patent: 0 815 861 (1998-01-01), None
patent: 1 104 763 (1999-08-01), None
patent: WO 94/22807 (1994-10-01), None
patent: WO 9813366 (1998-04-01), None
patent: WO 00/27820 (2000-05-01), None
patent: WO 200149289 (2001-07-01), None
patent: WO 0228353 (2002-04-01), None
patent: WO 200228353 (2002-04-01), None
patent: WO 02/089740 (2002-11-01), None
patent: WO 02/089785 (2002-11-01), None
patent: WO 02/089792 (2002-11-01), None
patent: WO 02/089793 (2002-11-01), None
patent: WO 02/090337 (2002-11-01), None
patent: WO 02/090348 (2002-11-01), None
patent: WO 02/090353 (2002-11-01), None
patent: WO 03/099773 (2003-12-01), None
patent: WO 2004/026836 (2004-04-01), None
Cohn, J. “The Management of Chronic Heart Failure,” N. Engl. J. Med., vol. 335(7), pp. 490-498 (Aug. 1996) at p. 493, col. 2, line 47 (Table 2).
Wu et al., J. Med. Chem. vol. 42, pp. 4485-4499 (1999).
Wu, et al., J. Med. Chem. (1999), vol. 42, pp. 4485-4499.
Silverman, R.B., “The Organic Chemistry of Drug Design and Drug Action” pp. 15-22 (1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenylenediamine Urotensin-II receptor antagonists and CCR-9... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenylenediamine Urotensin-II receptor antagonists and CCR-9..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylenediamine Urotensin-II receptor antagonists and CCR-9... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3911526

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.